Oligonucleotide drugs are made up of short sections of genetic sequences and are used to target disorders in the genetic code. The first drug of this type was used in 1998 during the AIDS epidemic. Since then, the field has accelerated rapidly and today many oligonucleotide drugs are in clinical trials, promising improvements in treatment Read More
From single-use valves for TFF to a redesigned sanitary safety relief valve, Equilibar and Steriflow have been exploring synergistic ways to combine two distinct technologies to create better fluid control solutions for the biopharmaceutical industry since 2021. As they prepare for the April 2024 INTERPHEX show in New York City, Single Use Technology Manager Ryan Read More
The Equilibar team is glad to send warm holiday wishes to our customers and partners around the world. We continue to be thankful for safety during Hurricane Helene and we’re grateful for all the agencies and individuals who are helping Western North Carolina recover. While Equilibar offices will be closed December 25th and 26th as well Read More
Read More